Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fibroquel
- Development stage
- Unknown
- Lead developer
- Aspid
- Modality
- Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Peptides
- Administration
- Intraarticular
01
Overview
Fibroquel is a biodynamic modulator and viscosupplement composed of a combination of type I collagen and polyvinylpyrrolidone (PVP). Administered via intra-articular injection, it is primarily used for the treatment of knee osteoarthritis, where it acts to improve joint function and reduce pain. Beyond its mechanical properties as a viscosupplement, Fibroquel is designed to modulate the local inflammatory environment within the joint by regulating the expression of cytokines and growth factors; specifically, it has been shown to decrease pro-inflammatory markers such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) while increasing anti-inflammatory factors like transforming growth factor-beta 1 (TGF-β1). The product has been evaluated in Phase 3 clinical trials in Mexico, demonstrating non-inferiority to established treatments like Hylan G-F 20 (Synvisc) in patients with Kellgren-Lawrence Grade II or III knee osteoarthritis.
- Brand names
- Fibroquel
- Other names
- Collagen-PVPCollagen-polyvinylpyrrolidoneCollagen-polyvinyl pyrrolidone
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)TGFB1 (Transforming growth factor Beta-1 proprotein)
Beyond the preview
Go deeper on Fibroquel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fibroquel.